Elsevier

Vaccine

Volume 10, Issue 7, 1992, Pages 461-468
Vaccine

Intranasal immunization with bacterial polysaccharide containing liposomes enhances antigen-specific pulmonary secretory antibody response

https://doi.org/10.1016/0264-410X(92)90395-ZGet rights and content

Abstract

Enhancement of bacterial antigen-specific secretory IgA (sIgA) titres in the lungs may enhance resistance to infections, such as pneumonia, occurring at this mucosal surface. To examine this issue, we intranasally administered liposomes containing bacterial polysaccharide antigens from Aerobacter levanicum, Pseudomonas aeruginosa and Streptococcus pneumoniae. In each case, increased titres of bacterial polysaccharide-specific sIgA could be achieved in the lungs following intranasal immunization with antigen encapsulated in liposomes. In comparison with oral immunization, which required high doses of polysaccharide antigen even when coadministered with adjuvant, intranasal administration of liposomes containing polysaccharide antigens achieved a similar pulmonary sIgA response with approximately 1/30 the amount of antigen necessary with oral immunization. In the case of P. aeruginosa, the magnitude of the sIgA response following intranasal immunization was sufficient to significantly reduce mortality from pneumonia produced by this organism. These results demonstrate that liposome-based mucosal immunization strategies can induce increased bacterial polysaccharide antigen-specific sIgA titres in the lung, and reduce susceptibility to pneumonia.

References (50)

  • H. Schreier

    A radiolabel and electron microscopy study of the interaction of liposomes with synaptosomal membranes

    Life Sciences

    (1989)
  • I.M. Ledingham et al.

    Triple regimen of selective decontamination of the digestive tract, systemic cefotaxime, and microbiological surveillance for prevention of acquired infection in intensive care

    Lancet

    (1988)
  • A.L. Davis et al.

    Pneumococcal infection and immunologic response to pneumococcal vaccine in chronic obstructive pulmonary disease

    Chest

    (1987)
  • G.B. Pier et al.

    Protective immunity induced in mice by immunization with high-molecular-weight polysaccharide from Pseudomonas aeruginosa

    Infect Immunol.

    (1978)
  • K.E. Stein et al.

    Neonatal administration of idiotype or antiidiotype primes for protection against Escherichia coli K13 infection in mice

    J. Exp. Med.

    (1984)
  • J.R. Schreiber et al.

    Anti-idiotype-induced, lipopolysaccharide-specific antibody response to Pseudomonas aeruginosa

  • S.J. Cryz et al.

    Use of Pseudomonas aeruginosa toxin A in the construction of conjugate vaccines and immunotoxins

    Rev. Infect. Dis.

    (1987)
  • H. Snippe et al.

    Preparation of a semisynthetic vaccine to Streptococcus pneumoniae type 3

    Infect. Immun.

    (1983)
  • B.J. Underdown et al.

    Immunoglobulin A: Strategic defense initiative at the mucosal surface

    Annu. Rev. Immunol.

    (1986)
  • E.S. Fubara et al.

    Protection against enteric bacterial infection by secretory IgA antibodies

    J. Immunol.

    (1973)
  • A. Tagliabue et al.

    Antibody-dependent cell-mediated antibacterial activity of intestinal lymphocytes with secretory IgA

    Nature

    (1983)
  • D. Bessen et al.

    Passive acquired mucosal immunity to group A streptococci by secretory immunoglobulin A

    J. Exp. Med.

    (1988)
  • J. Bienenstock et al.

    Mucosal immunology

    Immunology

    (1980)
  • M.B. Mazanec et al.

    Transport of serum IgA into murine respiratory secretions and its implications for immunization strategies

    J. Immunol.

    (1989)
  • K.-S. Chen et al.

    Active synthesis of hemagglutinin-specific immunoglobulin A by lung cells of mice that were immunized intragastrically with inactivated influenza virus vaccine

    J. Virol.

    (1987)
  • Cited by (71)

    • Development and characterization of gels and liposomes containing ovalbumin for nasal delivery

      2018, Journal of Drug Delivery Science and Technology
      Citation Excerpt :

      The negative zeta potential results from the egg-PC of the liposome formulation and ionization of the phosphate groups of the phosphatidyl choline. This suggestion is in line with the literature references [36,37]. Zeta potentials of the liposomes are affected by phospholipid concentration [38], active substances [39] and excipients [40,41].

    • Enhanced efficacy and immunogenicity of 78 kDa antigen formulated in various adjuvants against murine visceral leishmaniasis

      2010, Vaccine
      Citation Excerpt :

      The increased level of antibody was probably due to the masking of 78 kDa antigen by encapsulation in liposome. The response to the antigen require uptake, processing, and presentation of the liposomal antigen by antigen presenting cells (APC) with subsequent involvement of antigen specific T cells, resulting in a T-cell-dependent IgG response [99,100]. Also, liposomes specifically improve the antigen uptake by APCs such as macrophages.

    • Polysaccharides as carriers of bioactive agents for medical applications

      2008, Natural-Based Polymers for Biomedical Applications
    View all citing articles on Scopus
    View full text